REGENERON PHARMACEUTICALS INC
Action · US75886F1075 · REGN · 881535 (XNAS)
494,00 USD
06.06.2025 20:42
Cours actuels de REGENERON PHARMACEUTICALS INC
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NASDAQ |
REGN
|
USD
|
06.06.2025 20:42
|
494,00 USD
| 483,07 USD
+2,26 %
|
![]() London |
0R2M.L
|
USD
|
06.06.2025 15:13
|
496,04 USD
| 483,07 USD
+2,68 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | 0,55 % | -11,55 % | -29,27 % | -36,39 % | -50,84 % | -17,25 % |
Profil de l'entreprise pour REGENERON PHARMACEUTICALS INC Action
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Fonds investis
Les fonds suivants ont investi dans : REGENERON PHARMACEUTICALS INC investi :
Fonds | Vol. en millions 2.094,68 | Part (%) 4,91 % |
Fonds | Vol. en millions 23.196,45 | Part (%) 1,33 % |
Fonds | Vol. en millions 1.295,63 | Part (%) 1,25 % |
Fonds | Vol. en millions 33,86 | Part (%) 1,25 % |
Fonds | Vol. en millions 3.294,59 | Part (%) 0,90 % |
Données de l'entreprise
Nom REGENERON PHARMACEUTICALS INC
Société Regeneron Pharmaceuticals, Inc.
Symbole REGN
Site web
https://www.regeneron.com
Marché d'origine
NASDAQ

WKN 881535
ISIN US75886F1075
Type de titre Action
Secteur Healthcare
Industrie Medical - Pharmaceuticals
PDG Dr. Leonard S. Schleifer M.D., Ph.D.
Capitalisation boursière 60 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 15,1 T
Adresse 777 Old Saw Mill River Road, 10591-6707 Tarrytown
Date d'introduction en bourse 2014-11-05
Dividendes de 'REGENERON PHARMACEUTICALS INC'
Date ex-dividende | Dividende par action |
---|---|
20.05.2025 | 0,88 USD |
20.02.2025 | 0,88 USD |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | RGO.F |
London | 0R2M.L |
NASDAQ | REGN |
Autres actions
Les investisseurs qui détiennent REGENERON PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.